Global Bone Mineral Testing 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI07252397

Publication Date:

July 2, 2025

Pages:

102

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Bone Mineral Testing market size is predicted to grow from US$ 1092 million in 2025 to US$ 1921 million in 2031; it is expected to grow at a CAGR of 9.9% from 2025 to 2031.
Bone Mineral Testing refers to diagnostic testing for bone metabolism markers of blood markers . These tests are crucial for assessing the risk of bone diseases, such as osteoporosis, which is characterized by low bone mass and increased fracture risk. Bone mineral testing is often used to diagnose, monitor, and evaluate bone health in patients, especially postmenopausal women, older adults, and individuals with risk factors for bone loss.
The bone mineral testing market is growing rapidly, driven by the following factors: aging population, increasing awareness of bone health, and growing demand for precision medicine and personalized treatment. With technological advances and changes in consumer demand, the market for bone marker testing kits has shown strong growth potential.
Although the attention paid to bone health has increased, bone marker detection kits are still in the promotion stage, and many potential users are not aware of the technology, especially in developing countries and regions. How to increase market awareness and promote popularization and application is an important challenge.
From a regional perspective, North America, especially the United States, is one of the main markets for the bone mineral testing market. The region has a large aging population and a large demand for early diagnosis of osteoporosis, and the market demand continues to grow.
With the improvement of medical conditions and the increase of health awareness, the market prospects in the Asia-Pacific region are very broad.
Common bone markers include bone formation markers such as P1NP, CTX, TRACP-5b, BAP, etc. Among them, P1NP accounts for the largest proportion, reaching 39% in 2023.
The global key manufacturers of bone mineral testing include Roche, BioMerieux, Immunodiagnostic Systems (IDS), Bio-Rad Laboratories, DiaSorin, Immundiagnostik, QuidelOrtho and Snibe, etc. In 2023, in term of revenue of bone mineral testing, the top five companies hold a share nearly 56%.
With the advancement of technology, bone mineral testing may develop towards intelligence and portability. For example, the application of mobile devices and portable testing equipment can make it more convenient for patients to undergo testing, especially in remote areas.
The 鈥淏one Mineral Testing Industry Forecast鈥� looks at past sales and reviews total world Bone Mineral Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Bone Mineral Testing sales for 2025 through 2031. With Bone Mineral Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Mineral Testing industry.
This Insight Report provides a comprehensive analysis of the global Bone Mineral Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bone Mineral Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bone Mineral Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Mineral Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Mineral Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone Mineral Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Bone Metabolism Testing
Bone Formation Testing
Others
Segmentation by Application:
Hospital
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
BioMerieux
Immunodiagnostic Systems (IDS)
Bio-Rad Laboratories
DiaSorin
Immundiagnostik
QuidelOrtho
Snibe
Takara Bio
Aidian
Phicon
Biomedica
Novus Biologicals
Eagle Biosciences
Krishgen

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bone Mineral Testing 麻豆原创 Size (2020-2031)
2.1.2 Bone Mineral Testing 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Bone Mineral Testing by Country/Region (2020, 2024 & 2031)
2.2 Bone Mineral Testing Segment by Type
2.2.1 Bone Metabolism Testing
2.2.2 Bone Formation Testing
2.2.3 Others
2.3 Bone Mineral Testing 麻豆原创 Size by Type
2.3.1 Bone Mineral Testing 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Bone Mineral Testing 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Bone Mineral Testing Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.4.3 Others
2.5 Bone Mineral Testing 麻豆原创 Size by Application
2.5.1 Bone Mineral Testing 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Bone Mineral Testing 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Bone Mineral Testing 麻豆原创 Size by Player
3.1 Bone Mineral Testing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Bone Mineral Testing Revenue by Player (2020-2025)
3.1.2 Global Bone Mineral Testing Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Bone Mineral Testing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bone Mineral Testing by Region
4.1 Bone Mineral Testing 麻豆原创 Size by Region (2020-2025)
4.2 Global Bone Mineral Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bone Mineral Testing 麻豆原创 Size Growth (2020-2025)
4.4 APAC Bone Mineral Testing 麻豆原创 Size Growth (2020-2025)
4.5 Europe Bone Mineral Testing 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Bone Mineral Testing 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Bone Mineral Testing 麻豆原创 Size by Country (2020-2025)
5.2 Americas Bone Mineral Testing 麻豆原创 Size by Type (2020-2025)
5.3 Americas Bone Mineral Testing 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone Mineral Testing 麻豆原创 Size by Region (2020-2025)
6.2 APAC Bone Mineral Testing 麻豆原创 Size by Type (2020-2025)
6.3 APAC Bone Mineral Testing 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bone Mineral Testing 麻豆原创 Size by Country (2020-2025)
7.2 Europe Bone Mineral Testing 麻豆原创 Size by Type (2020-2025)
7.3 Europe Bone Mineral Testing 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bone Mineral Testing by Region (2020-2025)
8.2 Middle East & Africa Bone Mineral Testing 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Bone Mineral Testing 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Bone Mineral Testing 麻豆原创 Forecast
10.1 Global Bone Mineral Testing Forecast by Region (2026-2031)
10.1.1 Global Bone Mineral Testing Forecast by Region (2026-2031)
10.1.2 Americas Bone Mineral Testing Forecast
10.1.3 APAC Bone Mineral Testing Forecast
10.1.4 Europe Bone Mineral Testing Forecast
10.1.5 Middle East & Africa Bone Mineral Testing Forecast
10.2 Americas Bone Mineral Testing Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Bone Mineral Testing Forecast
10.2.2 Canada 麻豆原创 Bone Mineral Testing Forecast
10.2.3 Mexico 麻豆原创 Bone Mineral Testing Forecast
10.2.4 Brazil 麻豆原创 Bone Mineral Testing Forecast
10.3 APAC Bone Mineral Testing Forecast by Region (2026-2031)
10.3.1 China Bone Mineral Testing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Bone Mineral Testing Forecast
10.3.3 Korea 麻豆原创 Bone Mineral Testing Forecast
10.3.4 Southeast Asia 麻豆原创 Bone Mineral Testing Forecast
10.3.5 India 麻豆原创 Bone Mineral Testing Forecast
10.3.6 Australia 麻豆原创 Bone Mineral Testing Forecast
10.4 Europe Bone Mineral Testing Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Bone Mineral Testing Forecast
10.4.2 France 麻豆原创 Bone Mineral Testing Forecast
10.4.3 UK 麻豆原创 Bone Mineral Testing Forecast
10.4.4 Italy 麻豆原创 Bone Mineral Testing Forecast
10.4.5 Russia 麻豆原创 Bone Mineral Testing Forecast
10.5 Middle East & Africa Bone Mineral Testing Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Bone Mineral Testing Forecast
10.5.2 South Africa 麻豆原创 Bone Mineral Testing Forecast
10.5.3 Israel 麻豆原创 Bone Mineral Testing Forecast
10.5.4 Turkey 麻豆原创 Bone Mineral Testing Forecast
10.6 Global Bone Mineral Testing Forecast by Type (2026-2031)
10.7 Global Bone Mineral Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Bone Mineral Testing Forecast
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Bone Mineral Testing Product Offered
11.1.3 Roche Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 BioMerieux
11.2.1 BioMerieux Company Information
11.2.2 BioMerieux Bone Mineral Testing Product Offered
11.2.3 BioMerieux Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 BioMerieux Main Business Overview
11.2.5 BioMerieux Latest Developments
11.3 Immunodiagnostic Systems (IDS)
11.3.1 Immunodiagnostic Systems (IDS) Company Information
11.3.2 Immunodiagnostic Systems (IDS) Bone Mineral Testing Product Offered
11.3.3 Immunodiagnostic Systems (IDS) Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Immunodiagnostic Systems (IDS) Main Business Overview
11.3.5 Immunodiagnostic Systems (IDS) Latest Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Information
11.4.2 Bio-Rad Laboratories Bone Mineral Testing Product Offered
11.4.3 Bio-Rad Laboratories Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Bio-Rad Laboratories Main Business Overview
11.4.5 Bio-Rad Laboratories Latest Developments
11.5 DiaSorin
11.5.1 DiaSorin Company Information
11.5.2 DiaSorin Bone Mineral Testing Product Offered
11.5.3 DiaSorin Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 DiaSorin Main Business Overview
11.5.5 DiaSorin Latest Developments
11.6 Immundiagnostik
11.6.1 Immundiagnostik Company Information
11.6.2 Immundiagnostik Bone Mineral Testing Product Offered
11.6.3 Immundiagnostik Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Immundiagnostik Main Business Overview
11.6.5 Immundiagnostik Latest Developments
11.7 QuidelOrtho
11.7.1 QuidelOrtho Company Information
11.7.2 QuidelOrtho Bone Mineral Testing Product Offered
11.7.3 QuidelOrtho Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 QuidelOrtho Main Business Overview
11.7.5 QuidelOrtho Latest Developments
11.8 Snibe
11.8.1 Snibe Company Information
11.8.2 Snibe Bone Mineral Testing Product Offered
11.8.3 Snibe Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Snibe Main Business Overview
11.8.5 Snibe Latest Developments
11.9 Takara Bio
11.9.1 Takara Bio Company Information
11.9.2 Takara Bio Bone Mineral Testing Product Offered
11.9.3 Takara Bio Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Takara Bio Main Business Overview
11.9.5 Takara Bio Latest Developments
11.10 Aidian
11.10.1 Aidian Company Information
11.10.2 Aidian Bone Mineral Testing Product Offered
11.10.3 Aidian Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Aidian Main Business Overview
11.10.5 Aidian Latest Developments
11.11 Phicon
11.11.1 Phicon Company Information
11.11.2 Phicon Bone Mineral Testing Product Offered
11.11.3 Phicon Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Phicon Main Business Overview
11.11.5 Phicon Latest Developments
11.12 Biomedica
11.12.1 Biomedica Company Information
11.12.2 Biomedica Bone Mineral Testing Product Offered
11.12.3 Biomedica Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Biomedica Main Business Overview
11.12.5 Biomedica Latest Developments
11.13 Novus Biologicals
11.13.1 Novus Biologicals Company Information
11.13.2 Novus Biologicals Bone Mineral Testing Product Offered
11.13.3 Novus Biologicals Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Novus Biologicals Main Business Overview
11.13.5 Novus Biologicals Latest Developments
11.14 Eagle Biosciences
11.14.1 Eagle Biosciences Company Information
11.14.2 Eagle Biosciences Bone Mineral Testing Product Offered
11.14.3 Eagle Biosciences Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Eagle Biosciences Main Business Overview
11.14.5 Eagle Biosciences Latest Developments
11.15 Krishgen
11.15.1 Krishgen Company Information
11.15.2 Krishgen Bone Mineral Testing Product Offered
11.15.3 Krishgen Bone Mineral Testing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Krishgen Main Business Overview
11.15.5 Krishgen Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.